GlassScriptPhysician profile
Gregory Alergant
NPI 1003896457
$3,330.42
in general payments reported to CMS, 2019-2025
24 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $262 · 2021: $267 · 2022: $600 · 2023: $834 · 2024: $584 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,602.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $346.45 | 2023-2024 | Nuzyra |
| Kerecis Limited | $290.81 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Abbott Laboratories | $251.97 | 2022-2023 | Diamondback Peripheral |
| Globus Medical, INC. | $184.12 | 2025 | Senza |
| Nevro Corp. | $165.85 | 2022 | |
| Aroa Biosurgery Incorporated | $153.21 | 2020 | |
| Djo, LLC | $147.66 | 2019 | |
| Treace Medical Concepts, INC. | $135.46 | 2022 | |
| Acera Surgical, INC. | $130.18 | 2024 | Restrata Wound Matrix |
| Polynovo North America LLC | $127.13 | 2024 | Novosorb Btm |
| Leo Pharma INC. | $125.04 | 2023 | Adbry |
| Horizon Therapeutics Plc | $125.00 | 2023 | Krystexxa |
| Organogenesis INC. | $125.00 | 2021 | |
| Ibsa Pharma INC. | $125.00 | 2023 | Licart |
| Amgen INC. | $125.00 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $118.00 | 2022 | |
| Tactile Systems Technology INC | $108.60 | 2020 | |
| Averitas Pharma INC. | $105.47 | 2024 | Qutenza |
| Wright Medical Technology, INC. | $97.89 | 2019 | |
| Kci USA, INC. | $96.34 | 2019 | |
| Sun Pharmaceutical Industries INC. | $89.29 | 2022 | |
| Medtronic Vascular, INC. | $86.31 | 2019 | |
| Polarityte, INC. | $46.93 | 2019 | |
| Abbvie INC. | $23.71 | 2023 | Dalvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Alergant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.